Concepedia

Cost-effectiveness analysis of anastrozole versus tamoxifen as primary adjuvant therapy for postmenopausal women with early breast cancer: a US healthcare system perspective. The 5-year completed treatment analysis of the ATAC (‘Arimidex’, Tamoxifen Alone or in Combination) trial

Gershon Y. Locker, Robert E. Mansel, David Cella, Deborah Dobrez, Sonja Sorensen, Sanjay Gandhi

Breast Cancer Research and Treatment · 2007 · 74 citations · 17 references

DOI

Concepts

References

17

Tamoxifen for early breast cancer: an overview of the randomised trials

The Lancet · 1998 · 4.1K citations

, , +10

Markov Models in Medical Decision Making

Frank A. Sonnenberg, J. Robert Beck · Medical Decision Making · 1993 · 2.4K citations

, , +21

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

Anthony Howell, Jack Cuzick, M Baum et al. · The Lancet · 2005 · 2.3K citations

, , +8

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

C. Focan, S. M. Steinberg, M Blichert-Toft et al. · PubMed · 1998 · 2.2K citations

Costs, effects and C/E‐ratios alongside a clinical trial

Ben A. van Hout, Maiwenn Al, Gilad S. Gordon et al. · Health Economics · 1994 · 966 citations